129 related articles for article (PubMed ID: 38863630)
21. Efficacy and pregnancy outcomes of hysteroscopic surgery combined with progestin as fertility-sparing therapy in patients with early stage endometrial cancer and atypical hyperplasia.
Xi Y; Liu G; Liu D; Jiang J; Gong R
Arch Gynecol Obstet; 2023 Feb; 307(2):583-590. PubMed ID: 35674831
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment.
Zhou S; Xu Z; Yang B; Guan J; Shan W; Shi Y; Chen X
J Gynecol Oncol; 2021 Jul; 32(4):e57. PubMed ID: 34085795
[TBL] [Abstract][Full Text] [Related]
23. Hysteroscopic treatments for endometrial malignancies and premalignancies: state of the art.
Kahramanoglu I
Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):272-277. PubMed ID: 34289318
[TBL] [Abstract][Full Text] [Related]
24. Effects of Weight Status and Related Metabolic Disorders on Fertility-Sparing Treatment Outcomes in Endometrial Atypical Hyperplasia and Endometrial Cancer: A Retrospective Study.
Liu S; Wang L; Wu P; Luo S; Shan W; Chen X; Luo X
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291808
[TBL] [Abstract][Full Text] [Related]
25. PPOS Protocol Effectively Improves the IVF Outcome Without Increasing the Recurrence Rate in Early Endometrioid Endometrial Cancer and Atypical Endometrial Hyperplasia Patients After Fertility Preserving Treatment.
Chen J; Cheng Y; Fu W; Peng X; Sun X; Chen H; Chen X; Yu M
Front Med (Lausanne); 2021; 8():581927. PubMed ID: 34386503
[No Abstract] [Full Text] [Related]
26. A Clinicopathological Review of 203 Cases of Atypical Polypoid Adenomyoma of the Uterus.
Sun Y; Tian L; Liu G
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836047
[TBL] [Abstract][Full Text] [Related]
27. Hysteroscopic transcervical resection is useful to diagnose myometrial invasion in atypical polypoid adenomyoma coexisting with atypical endometrial hyperplasia or endometrial cancer with suspicious myometrial invasion.
Yamagami W; Susumu N; Ninomiya T; Nakadaira N; Iwasa N; Kuwahata M; Nomura H; Kataoka F; Banno K; Aoki D
J Obstet Gynaecol Res; 2015 May; 41(5):768-75. PubMed ID: 25491392
[TBL] [Abstract][Full Text] [Related]
28. Pregnant outcomes of atypical polypoid adenomyoma treated with progestin therapy.
Chen Q; Lu W; Lu B
J Obstet Gynaecol Res; 2018 Feb; 44(2):323-330. PubMed ID: 29121416
[TBL] [Abstract][Full Text] [Related]
29. Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma.
Nomura H; Sugiyama Y; Tanigawa T; Matoda M; Okamoto S; Omatsu K; Kanao H; Kato K; Utsugi K; Takeshima N
Jpn J Clin Oncol; 2018 Mar; 48(3):255-258. PubMed ID: 29351618
[TBL] [Abstract][Full Text] [Related]
30. Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta-analysis.
Zhao S; Zhang J; Yan Y; Tian L; Chen L; Zheng X; Sun Y; Tian W; Xue F; Wang Y
Acta Obstet Gynecol Scand; 2024 Feb; ():. PubMed ID: 38382917
[TBL] [Abstract][Full Text] [Related]
31. The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary.
Gama Q; Luo S; Wu P; Wang L; Liu S; Zhang H; Sun L; Wang Y; Yu M; Chen X; Shan W; Luo X
J Ovarian Res; 2023 Dec; 16(1):235. PubMed ID: 38062462
[TBL] [Abstract][Full Text] [Related]
32. Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
He Y; Wang Y; Zhou R; Wang J
Int J Gynecol Cancer; 2020 Dec; 30(12):1902-1907. PubMed ID: 33051245
[TBL] [Abstract][Full Text] [Related]
33. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study.
Raffone A; Catena U; Travaglino A; Masciullo V; Spadola S; Della Corte L; Piermattei A; Insabato L; Zannoni GF; Scambia G; Zullo F; Bifulco G; Fanfani F; Di Spiezio Sardo A
Gynecol Oncol; 2021 Jun; 161(3):795-801. PubMed ID: 33812697
[TBL] [Abstract][Full Text] [Related]
34. [GnRH-a combined fertility-sparing re-treatment in women with endometrial carcinoma or atypical endomertial hyperplasia who failed to oral progestin therapy].
Chen JY; Cao DY; Zhou HM; Yu M; Yang JX; Wang JH; Zhang Y; Cheng NH; Peng P
Zhonghua Fu Chan Ke Za Zhi; 2021 Aug; 56(8):561-568. PubMed ID: 34420288
[No Abstract] [Full Text] [Related]
35. Atypical polypoid adenomyoma treated by hysteroscopy with photodynamic diagnosis using 5-aminolevulinic acid: A case report.
Matoba Y; Banno K; Kobayashi Y; Kisu I; Aoki D
Photodiagnosis Photodyn Ther; 2019 Sep; 27():295-297. PubMed ID: 31252140
[TBL] [Abstract][Full Text] [Related]
36. Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia.
Zhang X; Chen D; Zhao X; Wang C; He Y; Chen Y; Wang J; Shen D
Pathol Res Pract; 2023 Jan; 241():154278. PubMed ID: 36580798
[TBL] [Abstract][Full Text] [Related]
37. The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer.
Guan J; Chen XJ
Front Endocrinol (Lausanne); 2022; 13():1041535. PubMed ID: 36387903
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
Zhou H; Cao D; Yang J; Shen K; Lang J
Int J Gynecol Cancer; 2017 Jul; 27(6):1178-1182. PubMed ID: 28562472
[TBL] [Abstract][Full Text] [Related]
39. Atypical polypoid adenomyomas progressed to endometrial endometrioid adenocarcinomas.
Zhang HK; Chen WD
Arch Gynecol Obstet; 2012 Sep; 286(3):707-10. PubMed ID: 22552378
[TBL] [Abstract][Full Text] [Related]
40. Management of atypical polypoid adenomyomas. A case series.
Grimbizis GF; Mikos T; Miliaras D; Kioussis G; Theodoridis TD; Tsolakidis D; Tarlatzis BC
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():1-5. PubMed ID: 28578202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
